Lynda Groocock

3PUBLICATIONS
43CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 11, 2026
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma.

Deborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas

|Nov 24, 2025
Discovery and Characterization of Novel BLIMP-1 Heterobifunctional Ligand-Directed Degraders.

Bryan J Simmons, Lynda Groocock, Jesus Moreno

|Nov 03, 2025
Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma.

Zhongying Mo, Lynda Groocock, Scott Wood

Pageof 1